Form D Explorer
Abingworth Clinical Co-Development Fund 3 LP · CIK 2049495

Report a data issueCitable research briefCompare issuerPrivate research collection

Abingworth Clinical Co-Development Fund 3 LP

CIK 2049495 · Limited Partnership · Inc. DELAWARE · WASHINGTON, District of Columbia · Pooled Investment Fund

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
1
Amendments
0
Activity
Jun 25, 2025
through Jun 25, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jun 25, 2025

Reported offering amount
—
Reported exemptions
Rule 506(c), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
Reported amount sold
$0

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Related person name and locality match

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (1)